INCYTE CORP — Regulatory Filings 2016

Apr 18, 2016

*UNITED STATES*

*SECURITIES AND EXCHANGE COMMISSION*

*Washington, D.C. 20549*

*FORM 8-K*

*CURRENT REPORT*

*Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934*

Date of Report (Date of earliest event reported): April 12, 2016

*INCYTE CORPORATION*

(Exact name of registrant as specified in its charter)

Delaware (State or Other Jurisdiction of Incorporation) 0-27488 (Commission File Number) 94-3136539 (I.R.S. Employer Identification No.)

1801 Augustine Cut-Off
Wilmington, DE	19803
(Address of principal executive offices)	(Zip Code)

*(302) 498-6700*

(Registrant’s telephone number, including area code)

*N/A*

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SEQ.=1,FOLIO='',FILE='C:\JMS\105569\16-8521-1\task7893286\8521-1-ba.htm',USER='105569',CD='Apr 15 18:15 2016'

*Item 5.02 Departure of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers.*

On April 12, 2016, Richard S. Levy, Executive Vice President and Chief Drug Development Officer of Incyte Corporation (the “Company”), notified the Company of his intention to retire effective April 30, 2016.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\105569\16-8521-1\task7893286\8521-1-ba.htm',USER='105569',CD='Apr 15 18:15 2016'

*SIGNATURE*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: April 18, 2016

INCYTE CORPORATION
By:	/s/ Eric H. Siegel
	Eric H. Siegel
	Executive Vice President and
	General Counsel

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\105569\16-8521-1\task7893286\8521-1-ba.htm',USER='105569',CD='Apr 15 18:15 2016'